Tedor Pharma has recently made changes to its management team. Doug Drysdale was appointed president and chief executive officer in February 2018. Mr. Drysdale joined the company’s board in November 2017 and brings 28 years of pharmaceutical experience, most recently as chairman and chief executive officer of Pernix Therapeutics, and founding chief executive officer of Alvogen.   Also, Terry Novak joined the company in February 2018 as chief operating officer. Mr. Novak has more than 35 years ...